Pancreatic Cancer Research

ResearcherKanazawa UniversityActive in the last 2 years

Shintaro Yagi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7465-5761; OpenAlex author ID A5040080599. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
74
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 5 papers · 2025: none · 2026: 5 papers

Papers 13

  1. International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maximum standardized uptake value 4.0 thresh… Co-author DOI 10.1016/j.surg.2026.110503↗
  2. RAGE signaling inhibition prevents the malignant phenotypes of pancreatic ductal adenocarcinoma cells. Last author DOI 10.1038/s41598-026-48913-5↗
  3. Randomized phase III trial of gemcitabine plus nab-paclitaxel versus gemcitabine plus S-1 as neoadjuvant chemotherapy for resectable pancreatic cancer in geria… Co-author DOI 10.1093/jjco/hyag055↗
  4. Prognostic Impact of Major Pathologic Response After Preoperative Treatment in Resected Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Retrospective S… Co-author DOI 10.1097/sla.0000000000007052↗
  5. Prognostic significance of fibroblast senescence and senescence-associated secretory phenotype factor expression in the tumor microenvironment of pancreatic du… Last author DOI 10.3892/or.2025.9031↗
  6. Clinical impacts of positive intraepithelial neoplasia at pancreatic transection margin in pancreatic cancer surgery. Last author DOI 10.1016/j.pan.2024.02.005↗
  7. Morphology of the Dorsal Pancreatic Artery and Its Oncological Significance in Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000002327↗
  8. A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Ja… Co-author DOI 10.1186/s12885-024-11957-9↗
  9. [Two Cases of Portal Vein Stent Placement for Portal Vein Stenosis Due to Recurrence of Pancreatic Cancer]. Last author PMID 38449416↗
  10. Enhanced Germinal Center Reactions Within Tertiary Lymphoid Structures Following Neoadjuvant Chemotherapy and Intestinal Care-A Path to Robust Antitumor Immune… Last author PMID 39571990↗
  11. Left-posterior approach for artery-first en bloc resection in laparoscopic distal pancreatectomy for left-sided pancreatic cancer. Co-author DOI 10.1007/s00423-020-02021-8↗
  12. Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer. Co-author DOI 10.1007/s00595-019-01954-y↗
  13. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer. Co-author DOI 10.1245/s10434-017-6077-y↗

Closest collaborators

The 25 strongest of 74 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Isamu Makino · 7 shared papers, 2024–2026 · strength 1.71
  2. Mitsuyoshi Okazaki · 5 shared papers, 2024–2026 · strength 1.20
  3. Satoshi Takada · 4 shared papers, 2024–2026 · strength 0.89
  4. Etsuro Hatano · 5 shared papers, 2017–2026 · strength 0.81
  5. Naoki Ikenaga · 3 shared papers, 2024–2026 · strength 0.54
  6. Tetsuo Ohta · 2 shared papers, 2024 · strength 0.51
  7. Shigeru Marubashi · 2 shared papers, 2026 · strength 0.39
  8. Tsutomu Fujii · 2 shared papers, 2026 · strength 0.39
  9. Amane Takahashi · 2 shared papers, 2024–2026 · strength 0.35
  10. Yusuke Sano · 2 shared papers, 2024–2026 · strength 0.35
  11. Keiko Kamei · 2 shared papers, 2024–2026 · strength 0.35
  12. Naoto Gotohda · 2 shared papers, 2024–2026 · strength 0.35
  13. Seiko Hirono · 2 shared papers, 2024–2026 · strength 0.35
  14. Makoto Ueno · 2 shared papers, 2024–2026 · strength 0.35
  15. Michiaki Unno · 2 shared papers, 2024–2026 · strength 0.35
  16. Toshihiko Masui · 2 shared papers, 2020–2026 · strength 0.32
  17. Kazuyuki Nagai · 2 shared papers, 2020–2026 · strength 0.32
  18. Tomoharu Miyashita · 1 shared paper, 2026 · strength 0.32
  19. Yuto Kitano · 1 shared paper, 2026 · strength 0.32
  20. Takeo Shimasaki · 1 shared paper, 2026 · strength 0.32
  21. Hironori Minami · 1 shared paper, 2026 · strength 0.28
  22. Hirotaka Yuki · 1 shared paper, 2024 · strength 0.21
  23. Asahi Sato · 1 shared paper, 2026 · strength 0.21
  24. Yuichiro Uchida · 1 shared paper, 2026 · strength 0.21
  25. Masato Narita · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.